WEST PHARMACEUTICAL SERVICES, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of -3.50% for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-24.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2020-02-24
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2019 was -3.50%.
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2018 was -6.00%, a 142.55% decline from fiscal 2017.
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2017 was 14.10%.
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2016 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|
| 2019-12-31 | -3.50% 10-K · filed 2020-02-24 | |
| 2018-12-31 | -6.00% 10-K · filed 2020-02-24 | |
| 2017-12-31 | 14.10% 10-K · filed 2020-02-24 | -14.10% 10-K · filed 2018-02-26 |
| 2016-12-31 | 0.00% 10-K · filed 2019-02-28 | |
| 2015-12-31 | 0.00% 10-K · filed 2018-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |